Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Min Luo
Sun Yat-Sen University (SYSU) - State Key Laboratory of Oncology in South China
United States
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
56
TOTAL CITATIONS
1
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Predictive Nomogram for Hyperprogressive Disease During Anti-PD-1/PD-L1 Treatment in Patients With Advanced Non-Small Cell Lung Cancer
Number of pages: 27
Posted: 08 Jan 2021
Xueping Wang
,
Zhixing Guo
,
Xingping Wu
,
Da Chen
,
Fang Wang
,
Lewei Yang
, Min Luo,
Sainan An
,
Lamei Huang
,
Shaochong Wu
,
Chuan Yang
and
Li-wu Fu
Sun Yat-sen University (SYSU) - Department of Laboratory Medicine, Sun Yat-sen University (SYSU) - Department of Ultrasound, Sun Yat-sen University (SYSU) - Department of Laboratory Medicine, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Esophageal Cancer Institute, Sun Yat-sen University Cancer Center, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-Sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-Sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-Sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-Sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-Sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-Sen University (SYSU) - State Key Laboratory of Oncology in South China and Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China
Downloads
56
(1,000,027)
Citation
1
View PDF
Download
Abstract:
anti-PD-1/PD-L1, hyperprogressive disease, non-small cell lung cancer, nomogram
Feedback